Cerevance Media Center

Current News

July 21, 2020

Cerevance Expands Series B Financing to $65 Million

Cerevance, a private drug discovery and development company focused on brain diseases, has expanded its Series B financing round, adding $20 million to the $45 million that it announced in April.

READ FULL

April 14, 2020

Cerevance Closes $45 Million Series B Financing

Cerevance has closed a Series B financing, bringing in $45 million from new investors including GV (formerly Google Ventures), Bill Gates and Foresite Capital, as well as all of the company’s previous investors...

READ FULL

January 7, 2020

Cerevance Appoints Clinical Development Veteran Dr. Aoife Brennan to Board of Directors

Dr. Brennan is currently president and chief executive officer of Synlogic, Inc. (Nasdaq:SYBX), a clinical stage biotechnology company applying synthetic biology to beneficial microbes to develop novel, living medicines.

READ FULL

December 17, 2019

Cerevance Enters Research Collaboration with Takeda to Advance New Treatments for Gastrointestinal Disorders

Cerevance has formed a multi-year research alliance with Takeda Pharmaceutical Company Limited (“Takeda”) to identify novel target proteins expressed in the central nervous system and to develop new therapies against them for certain GI disorders.

READ FULL

News Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

October 18, 2023

Cerevance to Participate at the Leerink Biopharma Private Company Connect

Date:
Wednesday, October 25, 2023
Time:
Check for open times
Location:
Virtual
Media:
Scheduled Meetings
Read full

October 10, 2023

Cerevance to Participate at the 3rd Annual Needham Biotech Private Company Forum. Company management will host one-on-one meetings during the conference.

Date:
Tuesday, October 17, 2023
Time:
Check for open times
Location:
Virtual
Media:
Scheduled Meetings
Read full

October 4, 2023

Cerevance to Participate at the 2023 Life Sciences Private Company Showcase

Date:
Thursday, October 12, 2023
Time:
10:05 – 10:25am ET
Location:
New York, NY
Media:
Presentation
Read full

Events Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

August 14, 2023

A Covalent Binding Mode of a Pyrazole-Based CD38 Inhibitor

Doyle, K., Roberts, M., Harvey, J, Hewer, R., Zebisch, M., Rangel, V., Gu, M., Wu, Y., Yang, L., Carlton, M., Dawson, L. & Bürli, R.

Viewview

October 15, 2018

Species and Cell-Type Properties of Classically Defined Human and Rodent Neurons and Glia

Xu, X., Stoyanova, E.I., Lemiesz, A.E., Xing, J., Mash, D.C., Heintz, N.

Viewview